The results suggested that the anticancer properties of ginsenoside Rg1 may derive from its ability to inhibit invasion and migration, and that these processes are regulated in breast cancer cells through the NF-κB-mediated regulation of MMP-9 expression. The gene discussed is NFKB1; the disease is breast carcinoma.